BB Healthcare investment trust has raised £150m ahead of its initial public offering (IPO) on Friday, making it the third investment company to list on the stockmarket this year.
The trust is set to begin trading on the London Stock Exchange at 8am on Friday 2 December and has completed a fundraising of £150m ahead of this. The vehicle will be managed by Daniel Koller (pictured), who currently runs sister investment company BB Biotech, and Paul Major, who has 18 years experience in the healthcare industry. It will offer shareholders an annual target dividend of 3.5% and any discount to NAV will be managed via an annual redemption facility. What next for biotech sector under a Trump presidency? The trust will be a high conviction, long-only investment tru...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
